Jim cramer senses a 'Fake out' in rumored AstraZeneca, Bristol Myers Squibb $400 billion mega-merger Benzinga 14h Article paywall
AstraZeneca and Bristol-Myers Squibb: Megamerger reports leave us scratching our heads MorningStar.com 11h
AstraZeneca-Bristol Myers merger buzz puts patent expiration and deal economics in focus Benzinga 9h Article paywall
AstraZeneca in talks over £300bn mega-merger with US rival – reports Evening Standard 19h Article paywall